{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:01Z","timestamp":1783948741460,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pharming Healthcare Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01736-4","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:24:07Z","timestamp":1779218647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-3818","authenticated-orcid":false,"given":"Noga","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-2250","authenticated-orcid":false,"given":"Lawrence","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"4","key":"1736_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10875-021-00972-1","volume":"41","author":"TMA Adesanya","year":"2021","unstructured":"Adesanya TMA, Campbell CM, Cheng L, Ogbogu PU, Kahwash R (2021) C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19. J Clin Immunol 41(4):729\u2013732. https:\/\/doi.org\/10.1007\/s10875-021-00972-1","journal-title":"J Clin Immunol"},{"issue":"9","key":"1736_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A, Mattozzi S, C\u00e1rceles-Cordon M, Martinez-Heras E et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17(9):760\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(18)30244-8","journal-title":"Lancet Neurol"},{"issue":"3","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.medj.2024.01.011","volume":"5","author":"K Baillie","year":"2024","unstructured":"Baillie K, Davies HE, Keat SBK, Ladell K, Miners KL, Jones SA et al (2024) Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID. Med 5(3):239-253.e5. https:\/\/doi.org\/10.1016\/j.medj.2024.01.011","journal-title":"Med"},{"issue":"4","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/infdis\/jiab010","volume":"224","author":"P Bandopadhyay","year":"2021","unstructured":"Bandopadhyay P, D\u2019Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR et al (2021) Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19. J Infect Dis 224(4):565\u201374. https:\/\/doi.org\/10.1093\/infdis\/jiab010","journal-title":"J Infect Dis"},{"issue":"7","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41577-021-00634-8","volume":"22","author":"Z Bekassy","year":"2022","unstructured":"Bekassy Z, Lopatko Fagerstr\u00f6m I, Bader M, Karpman D (2022) Crosstalk between the renin\u2013angiotensin, complement and kallikrein\u2013kinin systems in inflammation. Nat Rev Immunol 22(7):411\u201328. https:\/\/doi.org\/10.1038\/s41577-021-00634-8","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.anai.2017.01.029","volume":"118","author":"JA Bernstein","year":"2017","unstructured":"Bernstein JA, Relan A, Harper JR, Riedl M (2017) Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Ann Allergy Asthma Immunol 118(4):452\u2013455. https:\/\/doi.org\/10.1016\/j.anai.2017.01.029","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1736_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420952901","volume":"13","author":"KM Blackburn","year":"2020","unstructured":"Blackburn KM, Wang C (2020) Post-infectious neurological disorders. Ther Adv Neurol Disord 13:1756286420952901. https:\/\/doi.org\/10.1177\/1756286420952901","journal-title":"Ther Adv Neurol Disord"},{"key":"1736_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188750","volume":"14","author":"E Bugbee","year":"2023","unstructured":"Bugbee E, Wang AA, Gommerman JL (2023) Under the influence: environmental factors as modulators of neuroinflammation through the IL-10\/IL-10R axis. Front Immunol 14:1188750. https:\/\/doi.org\/10.3389\/fimmu.2023.1188750","journal-title":"Front Immunol"},{"issue":"19","key":"1736_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7942","volume":"383","author":"C Cervia-Hasler","year":"2024","unstructured":"Cervia-Hasler C, Br\u00fcningk SC, Hoch T, Fan B, Muzio G, Thompson RC et al (2024) Persistent complement dysregulation with signs of thromboinflammation in active long Covid. Science 383(19):eadg7942. https:\/\/doi.org\/10.1126\/science.adg7942","journal-title":"Science"},{"issue":"1","key":"1736_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04133-4","volume":"25","author":"JR Chaganti","year":"2025","unstructured":"Chaganti JR, Talekar TK, Brew BJ (2025) Asymmetrical glymphatic dysfunction in patients with long Covid associated neurocognitive impairment- correlation with BBB disruption. BMC Neurol 25(1):112. https:\/\/doi.org\/10.1186\/s12883-025-04133-4","journal-title":"BMC Neurol"},{"issue":"1","key":"1736_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/neur.2022.0011","volume":"4","author":"M Chen","year":"2023","unstructured":"Chen M, Tieng QM, Du J, Edwards SR, Maskey D, Peshtenski E et al (2023) Effects of C1-INH treatment on neurobehavioral sequelae and late seizures after traumatic brain injury in a mouse model of controlled cortical impact. Neurotrauma Rep 4(1):124\u201336. https:\/\/doi.org\/10.1089\/neur.2022.0011","journal-title":"Neurotrauma Rep"},{"issue":"12","key":"1736_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41423-020-0410-2","volume":"17","author":"IT Chyuan","year":"2020","unstructured":"Chyuan IT, Hsu PN (2020) TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases. Cell Mol Immunol 17(12):1281\u20131283. https:\/\/doi.org\/10.1038\/s41423-020-0410-2","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"1736_CR13","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.4049\/jimmunol.2100788","volume":"208","author":"IT Chyuan","year":"2022","unstructured":"Chyuan IT, Chu CL, Hsu CL, Pan MH, Liao HJ, Wu CS et al (2022) T cell\u2013specific deletion of TRAIL receptor reveals its critical role for regulating pathologic T cell activation and disease induction in experimental autoimmune encephalomyelitis. J Immunol 208(7):1534\u201344. https:\/\/doi.org\/10.4049\/jimmunol.2100788","journal-title":"J Immunol"},{"issue":"3","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00262-012-1370-x","volume":"62","author":"Z Diao","year":"2013","unstructured":"Diao Z, Shi J, Zhu J, Yuan H, Ru Q, Liu S et al (2013) TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4\u2009+\u2009CD25+ Treg apoptosis. Cancer Immunol Immunother 62(4):653\u201363. https:\/\/doi.org\/10.1007\/s00262-012-1370-x","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1736_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941","volume":"29","author":"AA Divani","year":"2020","unstructured":"Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J et al (2020) Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis 29(8):104941. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104941","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/glia.23611","volume":"67","author":"D Farfara","year":"2019","unstructured":"Farfara D, Feierman E, Richards A, Revenko AS, MacLeod RA, Norris EH et al (2019) Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits. Glia 67(7):1359\u201373. https:\/\/doi.org\/10.1002\/glia.23611","journal-title":"Glia"},{"issue":"9","key":"1736_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","volume":"28","author":"U Felderhoff-Mueser","year":"2005","unstructured":"Felderhoff-Mueser U, Schmidt OI, Oberholzer A, B\u00fchrer C, Stahel PF (2005) IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 28(9):487\u201393. https:\/\/doi.org\/10.1016\/j.tins.2005.06.008","journal-title":"Trends Neurosci"},{"issue":"1","key":"1736_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jnc.15460","volume":"159","author":"E Gozal","year":"2021","unstructured":"Gozal E, Jagadapillai R, Cai J, Barnes GN (2021) Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood\u2013brain barrier integrity in autism spectrum disorder. J Neurochem 159(1):15\u201328. https:\/\/doi.org\/10.1111\/jnc.15460","journal-title":"J Neurochem"},{"issue":"24","key":"1736_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132772","volume":"10","author":"M Gudowska-Sawczuk","year":"2021","unstructured":"Gudowska-Sawczuk M, Mroczko B (2021) The role of Neuropilin-1 (NRP-1) in SARS-CoV-2 infection: review. J Clin Med 10(24):2772. https:\/\/doi.org\/10.3390\/jcm10132772","journal-title":"J Clin Med"},{"key":"1736_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clicom.2022.05.001","volume":"2","author":"MA Hausburg","year":"2022","unstructured":"Hausburg MA, Williams JS, Banton KL, Mains CW, Roshon M, Bar-Or D (2022) C1 esterase inhibitor-mediated immunosuppression in COVID-19: friend or foe? Clin Immunol Commun 2:83\u201390. https:\/\/doi.org\/10.1016\/j.clicom.2022.05.001","journal-title":"Clin Immunol Commun"},{"issue":"2","key":"1736_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12016-018-8684-1","volume":"56","author":"H Henry Li","year":"2019","unstructured":"Henry Li H, Riedl M, Kashkin J (2019) Update on the use of C1-esterase inhibitor replacement therapy in the acute and prophylactic treatment of hereditary angioedema. Clin Rev Allergy Immunol 56(2):207\u2013218. https:\/\/doi.org\/10.1007\/s12016-018-8684-1","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"1736_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/v15071498","volume":"15","author":"M Ishitoku","year":"2023","unstructured":"Ishitoku M, Mokuda S, Araki K, Watanabe H, Kohno H, Sugimoto T et al (2023) Tumor Necrosis Factor and Interleukin-1\u03b2 Upregulate NRP2 Expression and Promote SARS-CoV-2 Proliferation. Viruses 15(7):1498. https:\/\/doi.org\/10.3390\/v15071498","journal-title":"Viruses"},{"issue":"14","key":"1736_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142211","volume":"11","author":"R Jagadapillai","year":"2022","unstructured":"Jagadapillai R, Qiu X, Ojha K, Li Z, El-Baz A, Zou S et al (2022) Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity. Cells 11(14):2211. https:\/\/doi.org\/10.3390\/cells11142211","journal-title":"Cells"},{"issue":"1","key":"1736_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1067\/mai.2002.121316","volume":"109","author":"AP Kaplan","year":"2002","unstructured":"Kaplan AP, Joseph K, Silverberg M (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109(1):195\u2013209. https:\/\/doi.org\/10.1067\/mai.2002.121316","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.anai.2010.01.007","volume":"104","author":"AP Kaplan","year":"2010","unstructured":"Kaplan AP, Joseph K (2010) The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol 104(3):193\u2013204. https:\/\/doi.org\/10.1016\/j.anai.2010.01.007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"1736_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04198-1","volume":"25","author":"M Kim","year":"2025","unstructured":"Kim M, Lee KH, Ko JS, Kim MS, Choi KS, Seo J (2025) Neurologic symptoms as a hallmark of glymphatic alteration in recovered patients with COVID-19. BMC Neurol 25(1):187. https:\/\/doi.org\/10.1186\/s12883-025-04198-1","journal-title":"BMC Neurol"},{"key":"1736_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01312","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Ju X, Silveira PA, Abadir E, Hsu WH, Hart DNJ et al (2019) CD83: activation marker for antigen presenting cells and its therapeutic potential. Front Immunol 10:1312. https:\/\/doi.org\/10.3389\/fimmu.2019.01312","journal-title":"Front Immunol"},{"key":"1736_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100722","volume":"35","author":"EHT Lim","year":"2021","unstructured":"Lim EHT, Vlaar APJ, de-Bruin S, Brouwer MC, van-de-Beek D (2021) Complement inhibition in severe COVID-19 \u2013 blocking C5a seems to be key. EClinicalMedicine 35:100722. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100722","journal-title":"EClinicalMedicine"},{"key":"1736_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1523814","author":"I Melamed","year":"2025","unstructured":"Melamed I, Buckley C, Bayko ME, Williams JL, Or-Geva N (2025) Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2025.1523814","journal-title":"Front Neurol"},{"issue":"6\u20137","key":"1736_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuropharm.2009.02.007","volume":"56","author":"A Mirshafiey","year":"2009","unstructured":"Mirshafiey A, Mohsenzadegan M (2009) TGF-\u03b2 as a promising option in the treatment of multiple sclerosis. Neuropharmacology 56(6\u20137):929\u2013936. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.02.007","journal-title":"Neuropharmacology"},{"issue":"9","key":"1736_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01130-1","volume":"21","author":"N Moghimi","year":"2021","unstructured":"Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD et al (2021) The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep 21(9):44. https:\/\/doi.org\/10.1007\/s11910-021-01130-1","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1\u20132","key":"1736_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jneuroim.2013.07.013","volume":"263","author":"M Moreno","year":"2013","unstructured":"Moreno M, S\u00e1enz-Cuesta M, Castill\u00f3 J, Cant\u00f3 E, Negrotto L, Vidal-Jordana A et al (2013) Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis. J Neuroimmunol 263(1\u20132):152\u20134. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.07.013","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1736_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cbin.11232","volume":"44","author":"OO Mugisho","year":"2020","unstructured":"Mugisho OO, Robilliard LD, Nicholson LFB, Graham ES, O\u2019Carroll SJ (2020) Bradykinin receptor-1 activation induces inflammation and increases the permeability of human brain microvascular endothelial cells. Cell Biol Int 44(1):343\u2013351. https:\/\/doi.org\/10.1002\/cbin.11232","journal-title":"Cell Biol Int"},{"issue":"4","key":"1736_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"issue":"6","key":"1736_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(18)30144-3","volume":"17","author":"E Nobile-Orazio","year":"2018","unstructured":"Nobile-Orazio E (2018) The complement story in Guillain-Barr\u00e9 syndrome: from pathogenesis to therapy. Lancet Neurol 17(6):483\u2013485. https:\/\/doi.org\/10.1016\/S1474-4422(18)30144-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"1736_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12079-021-00652-0","volume":"16","author":"DAB Rex","year":"2022","unstructured":"Rex DAB, Deepak K, Vaid N, Dagamajalu S, Kandasamy RK, Flo TH et al (2022) A modular map of Bradykinin-mediated inflammatory signaling network. J Cell Commun Signal 16(1):301\u201310. https:\/\/doi.org\/10.1007\/s12079-021-00652-0","journal-title":"J Cell Commun Signal"},{"issue":"10","key":"1736_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100277","volume":"21","author":"VR Richard","year":"2022","unstructured":"Richard VR, Gaither C, Popp R, Chaplygina D, Brzhozovskiy A, Kononikhin A et al (2022) Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning. Mol Cell Proteomics 21(10):100277. https:\/\/doi.org\/10.1016\/j.mcpro.2022.100277","journal-title":"Mol Cell Proteomics"},{"key":"1736_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbi.2012.12.021","volume":"31","author":"HE Ross","year":"2013","unstructured":"Ross HE, Guo Y, Coleman K, Ousley O, Miller AH (2013) Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report. Brain Behav Immun 31:76\u201381. https:\/\/doi.org\/10.1016\/j.bbi.2012.12.021","journal-title":"Brain Behav Immun"},{"issue":"10","key":"1736_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01228","volume":"8","author":"S Roy","year":"2017","unstructured":"Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K (2017) Multifaceted role of Neuropilins in the immune system: potential targets for immunotherapy. Front Immunol 8(10):1228. https:\/\/doi.org\/10.3389\/fimmu.2017.01228","journal-title":"Front Immunol"},{"key":"1736_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2023.01.010","volume":"126","author":"M Seto","year":"2023","unstructured":"Seto M, Dumitrescu L, Mahoney ER, Sclafani AM, De Jager PL, Menon V et al (2023) Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer\u2019s disease. Neurobiol Aging 126:25\u201333. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.01.010","journal-title":"Neurobiol Aging"},{"key":"1736_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02839-4","author":"D Subramanian","year":"2024","unstructured":"Subramanian D, Eisenberg C, Huang A, Baek J, Naveed H, Komatireddy S et al (2024) Dysregulation of neuropilin-2 expression in inhibitory neurons impairs hippocampal circuit development and enhances risk for autism-related behaviors and seizures. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-024-02839-4","journal-title":"Mol Psychiatry"},{"issue":"4","key":"1736_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bjh.16938","volume":"190","author":"TM Thomson","year":"2020","unstructured":"Thomson TM, Toscano-Guerra E, Casis E, Paciucci R (2020) C1 esterase inhibitor and the contact system in COVID\u201019. Br J Haematol 190(4):520\u2013524. https:\/\/doi.org\/10.1111\/bjh.16938","journal-title":"Br J Haematol"},{"issue":"5","key":"1736_CR44","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2020.02.013","volume":"180","author":"EF Willis","year":"2020","unstructured":"Willis EF, MacDonald KPA, Nguyen QH, Garrido AL, Gillespie ER, Harley SBR et al (2020) Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell 180(5):833-846.e16. https:\/\/doi.org\/10.1016\/j.cell.2020.02.013","journal-title":"Cell"},{"issue":"8","key":"1736_CR45","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","volume":"43","author":"WM Zelek","year":"2022","unstructured":"Zelek WM, Morgan BP (2022) Targeting complement in neurodegeneration: challenges, risks, and strategies. Trends Pharmacol Sci 43(8):615\u2013628. https:\/\/doi.org\/10.1016\/j.tips.2022.02.006","journal-title":"Trends Pharmacol Sci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01736-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:01:26Z","timestamp":1783947686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01736-4","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.O., M.C., S.N., and L.S. declare no conflicts of interest. I.M. reports receiving an educational grant from Pharming Healthcare, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"111"}}